- Capstone secured distribution rights for Westlake Royal’s Eldorado Stone manufactured stone veneer brand.
- Management expects Eldorado Stone to add $5 million in annualized run-rate revenue by Q3 2027.
- Product will be sold through existing distribution channels, with no incremental infrastructure investment.
- Award expands Capstone’s relationship with Westlake Royal, where it already ranks as a top-three national distributor for Cultured Stone.
- Company targets positive corporate EBITDA run-rate beginning in Q2 2026, supported by Eldorado contribution and ongoing cost actions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capstone Therapeutics Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260406575709) on April 06, 2026, and is solely responsible for the information contained therein.
Comments